This story was first published in digitalhealth.net

The European Society for Bone and Marrow Transplantation annual conference has heard how a stem cell transplant could be a ‘game changer’ for many patients with multiple sclerosis (MS).
Over 100 patients took part in the trial, in hospitals in Chicago, Sheffield, Uppsala in Sweden and Sao Paolo in Brazil, and found that the transplant was able to stop the disease and improve symptoms. The result were based upon a trail which wiped out a patient's immune system using cancer drugs and then rebooting it with a stem cell transplant.
Approximately 100,000 people in the UK have MS, which, due to the condition affecting the brain and/or spinal cord, can cause problems with vision, arm or leg movement, sensation or balance.
As part of the trial, the patients received either haematopoietic stem cell transplantation (HSCT) or drug treatment, with only one relapse occurring among the stem cell group after one year compared with 39 in the drug group. A three-year follow up also showed that the transplants had failed in three out of 52 patients, compared with 30 of 50 in the control group.
Dr Susan Kohlhaas, director research at the MS Society, praised the results but advised caution over where HSCT fits in with other DMTs.
She said: “The MIST results are important and show this area needs further research. While HSCT appears to be effective for some people with MS, it remains a high-risk treatment that won’t be right for everyone. We now need to know how HSCT compares to existing, less aggressive, MS treatment options. HSCT will soon be recognised as an established treatment in England. And when that happens our priority will be making sure those who could benefit can actually get it. We’ve seen life changing results for some people and having that opportunity can’t depend on your postcode.”
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly